SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Holding(s) in Company

10 Nov 2020 09:26

RNS Number : 8222E
RTW Venture Fund Limited
10 November 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

RTW Venture Fund Limited

LEI: 549300Q7EXQQH6KF7Z84

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Share transfer by Roderick Wong into PGGL Family Trust LLC, which is wholly owned by Roderick Wong. No shares have been sold or purchased.

X

3. Details of person subject to the notification obligationiv

Name

Roderick Wong

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

29/10/2020

6. Date on which issuer notified (DD/MM/YYYY):

10/11/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

13.21%

0.00%

13.21%

187,833,366

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GG00BKTRRM22

24,814,619

13.21%

SUBTOTAL 8. A

24,814,619

13.21%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

PGGL Family Trust, LLC

13.21%

0.00%

13.21%

RTW Fund Group GP, LLC

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Roderick Wong is the 100% beneficial owner of the shares and voting rights held by PGGL Family Trust, LLC and RTW Fund Group GP, LLC.

 

Place of completion

New York, NY USA

Date of completion

10 November 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLURUKRRVUAARA
Date   Source Headline
12th Jun 20267:00 amRNSMonthly Valuation Update and Factsheet
11th Jun 20264:45 pmRNSResult of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 20267:00 amRNSNotice of AGM
14th May 20267:00 amRNSMonthly Valuation Update and Factsheet
12th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSAdditional investment in Windward Bio
6th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20263:00 pmRNSAnnual Financial Report
24th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSKailera completes $625 million IPO
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSReplacement RNS: Monthly Valuation Update
15th Apr 20267:01 amRNSObsidian Therapeutics reverse merger with Galera
15th Apr 20267:00 amRNSMonthly Valuation Update and Factsheet
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:01 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSApellis and Centessa to be acquired
31st Mar 20267:01 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSAmani closes $25 million Series A financing
30th Mar 20267:01 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Financial Report
27th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.